SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients

Sofie Leisby Antonsen; Annika Loft; Rune Vincents Fisker; Anne Lerberg Nielsen; Erik Søgaard Andersen; Estrid Høgdall; Ann Tabor; Kirsten Væver Jochumsen; Carsten L Fagö-Olsen; Jon Asmussen; Anne Kiil Berthelsen; Ib Jarle Christensen; Claus Høgdall

doi:10.1016/j.ygyno.2013.01.019

SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients

Sofie Leisby Antonsen, Annika Loft, Rune Vincents Fisker, Anne Lerberg Nielsen, Erik Søgaard Andersen, Estrid Høgdall, Ann Tabor, Kirsten Væver Jochumsen, Carsten L Fagö-Olsen, Jon Asmussen, Anne Kiil Berthelsen, Ib Jarle Christensen, Claus Høgdall

Abstract

Objective: To evaluate SUVmax in the assessment of endometrial cancer preoperatively with particular focus on myometrial invasion (MI), cervical invasion (CI), FIGO stage, risk-stratification and lymph node metastases (LNM). Methods: A total of 268 women with endometrial cancer or atypical endometrial hyperplasia underwent FDG PET/CT imaging before surgical treatment. SUVmax of the primary tumour was compared with histological prognostic factors. Results: SUVmax was significantly higher in patients with high FIGO stages (p < 0.0001), deep MI (p = 0.002), CI (p = 0.04), LNM (p = 0.04) and high risk tumours (p = 0.003). Linear regression found that SUVmax was dependent of MI (p = 0.001, 95% CI 2.863-11.098), CI (p = 0.001, 95% CI 2.896-11.499), risk (p = 0.004, 95% CI 0.077-0.397), LNM (p = 0.04, 95% CI 0.011-0.482) and FIGO stage (p < 0.0001, 95% CI 0.158-0.473). Conclusions: Preoperative PET/CT scanning and SUVmax measurements of the primary tumour may provide additional clinical and prognostic information about MI, CI, LNM and high risk disease in patients with endometrial cancer and allow for individualization of patient care. However, the sensitivity and specificity of the SUVmax in staging endometrial cancer is not high enough to reliably replace surgical staging.

Original language	English
Journal	Gynecologic Oncology
Volume	129
Issue number	2
Pages (from-to)	298-303
Number of pages	6
ISSN	0090-8258
DOIs	https://doi.org/10.1016/j.ygyno.2013.01.019
Publication status	Published - May 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ygyno.2013.01.019

Cite this

Antonsen, S. L., Loft, A., Fisker, R. V., Nielsen, A. L., Andersen, E. S., Høgdall, E., Tabor, A., Jochumsen, K. V., Fagö-Olsen, C. L., Asmussen, J., Berthelsen, A. K., Christensen, I. J., & Høgdall, C. (2013). SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients. Gynecologic Oncology, 129(2), 298-303. https://doi.org/10.1016/j.ygyno.2013.01.019

@article{1d64975fd03744b7a48c3e6edbbbcf2c,

title = "SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients",

abstract = "Objective: To evaluate SUVmax in the assessment of endometrial cancer preoperatively with particular focus on myometrial invasion (MI), cervical invasion (CI), FIGO stage, risk-stratification and lymph node metastases (LNM). Methods: A total of 268 women with endometrial cancer or atypical endometrial hyperplasia underwent FDG PET/CT imaging before surgical treatment. SUVmax of the primary tumour was compared with histological prognostic factors. Results: SUVmax was significantly higher in patients with high FIGO stages (p < 0.0001), deep MI (p = 0.002), CI (p = 0.04), LNM (p = 0.04) and high risk tumours (p = 0.003). Linear regression found that SUVmax was dependent of MI (p = 0.001, 95% CI 2.863-11.098), CI (p = 0.001, 95% CI 2.896-11.499), risk (p = 0.004, 95% CI 0.077-0.397), LNM (p = 0.04, 95% CI 0.011-0.482) and FIGO stage (p < 0.0001, 95% CI 0.158-0.473). Conclusions: Preoperative PET/CT scanning and SUVmax measurements of the primary tumour may provide additional clinical and prognostic information about MI, CI, LNM and high risk disease in patients with endometrial cancer and allow for individualization of patient care. However, the sensitivity and specificity of the SUVmax in staging endometrial cancer is not high enough to reliably replace surgical staging.",

author = "Antonsen, {Sofie Leisby} and Annika Loft and Fisker, {Rune Vincents} and Nielsen, {Anne Lerberg} and Andersen, {Erik S{\o}gaard} and Estrid H{\o}gdall and Ann Tabor and Jochumsen, {Kirsten V{\ae}ver} and Fag{\"o}-Olsen, {Carsten L} and Jon Asmussen and Berthelsen, {Anne Kiil} and Christensen, {Ib Jarle} and Claus H{\o}gdall",

year = "2013",

month = may,

doi = "10.1016/j.ygyno.2013.01.019",

language = "English",

volume = "129",

pages = "298--303",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press",

number = "2",

}

TY - JOUR

T1 - SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients

AU - Antonsen, Sofie Leisby

AU - Loft, Annika

AU - Fisker, Rune Vincents

AU - Nielsen, Anne Lerberg

AU - Andersen, Erik Søgaard

AU - Høgdall, Estrid

AU - Tabor, Ann

AU - Jochumsen, Kirsten Væver

AU - Fagö-Olsen, Carsten L

AU - Asmussen, Jon

AU - Berthelsen, Anne Kiil

AU - Christensen, Ib Jarle

AU - Høgdall, Claus

PY - 2013/5

Y1 - 2013/5

N2 - Objective: To evaluate SUVmax in the assessment of endometrial cancer preoperatively with particular focus on myometrial invasion (MI), cervical invasion (CI), FIGO stage, risk-stratification and lymph node metastases (LNM). Methods: A total of 268 women with endometrial cancer or atypical endometrial hyperplasia underwent FDG PET/CT imaging before surgical treatment. SUVmax of the primary tumour was compared with histological prognostic factors. Results: SUVmax was significantly higher in patients with high FIGO stages (p < 0.0001), deep MI (p = 0.002), CI (p = 0.04), LNM (p = 0.04) and high risk tumours (p = 0.003). Linear regression found that SUVmax was dependent of MI (p = 0.001, 95% CI 2.863-11.098), CI (p = 0.001, 95% CI 2.896-11.499), risk (p = 0.004, 95% CI 0.077-0.397), LNM (p = 0.04, 95% CI 0.011-0.482) and FIGO stage (p < 0.0001, 95% CI 0.158-0.473). Conclusions: Preoperative PET/CT scanning and SUVmax measurements of the primary tumour may provide additional clinical and prognostic information about MI, CI, LNM and high risk disease in patients with endometrial cancer and allow for individualization of patient care. However, the sensitivity and specificity of the SUVmax in staging endometrial cancer is not high enough to reliably replace surgical staging.

AB - Objective: To evaluate SUVmax in the assessment of endometrial cancer preoperatively with particular focus on myometrial invasion (MI), cervical invasion (CI), FIGO stage, risk-stratification and lymph node metastases (LNM). Methods: A total of 268 women with endometrial cancer or atypical endometrial hyperplasia underwent FDG PET/CT imaging before surgical treatment. SUVmax of the primary tumour was compared with histological prognostic factors. Results: SUVmax was significantly higher in patients with high FIGO stages (p < 0.0001), deep MI (p = 0.002), CI (p = 0.04), LNM (p = 0.04) and high risk tumours (p = 0.003). Linear regression found that SUVmax was dependent of MI (p = 0.001, 95% CI 2.863-11.098), CI (p = 0.001, 95% CI 2.896-11.499), risk (p = 0.004, 95% CI 0.077-0.397), LNM (p = 0.04, 95% CI 0.011-0.482) and FIGO stage (p < 0.0001, 95% CI 0.158-0.473). Conclusions: Preoperative PET/CT scanning and SUVmax measurements of the primary tumour may provide additional clinical and prognostic information about MI, CI, LNM and high risk disease in patients with endometrial cancer and allow for individualization of patient care. However, the sensitivity and specificity of the SUVmax in staging endometrial cancer is not high enough to reliably replace surgical staging.

U2 - 10.1016/j.ygyno.2013.01.019

DO - 10.1016/j.ygyno.2013.01.019

M3 - Journal article

SN - 0090-8258

VL - 129

SP - 298

EP - 303

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 2

ER -

SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this